Back

Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

3 September 2019 (08:48 - 09:06)
Organised by:
Congress Presentation Part of: Blood pressure targets in high risk patients: challenges and opportunities Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
State of the Art - Blood pressure targets in high risk patients : how low to go?
Professor S. MacMahon (Oxford, GB)
Slides Video
Presentation thumbnail
Different relationships between blood pressures and clinical events in SPRINT and ACCORD-BP trial
Associate Professor D. Shin (Seoul, KR)
Abstract
Presentation thumbnail
Is intensive blood pressure strategy effective and safe in patients with cardiovascular disease? The two sides of the coin
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Blood pressure targets in current guidelines: what's left unanswered?
Professor E. Shlyakhto (Saint Petersburg, RU)
Slides Video

Access the full session

Session thumbnail
Blood pressure targets in high risk patients: challenges and opportunities

The Event

Event poster

ESC Congress 2019

3 September 2019 08:48 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Webinar
Management of blood pressure: selected case-based advice
thumbnail
Congress Presentation
State-of-the-art lecture on pharmacotherapy in hypertension